Heart rate variability predicts the magnitude of heart rate decrease after fingolimod initiation. (Record no. 26668293)

MARC details
000 -LEADER
fixed length control field 01329 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517130154.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201702s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2211-0356
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.msard.2016.09.012
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Simula, Sakari
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170228
245 00 - TITLE STATEMENT
Title Heart rate variability predicts the magnitude of heart rate decrease after fingolimod initiation.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Multiple sclerosis and related disorders
Date of publication, distribution, etc. Nov 2016
300 ## - PHYSICAL DESCRIPTION
Extent 86-89 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disability Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Electrocardiography, Ambulatory
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fingolimod Hydrochloride
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heart Rate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunosuppressive Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Sclerosis, Relapsing-Remitting
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Laitinen, Tomi P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Laitinen, Tiina M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hartikainen, Päivi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hartikainen, Juha Ek
773 0# - HOST ITEM ENTRY
Title Multiple sclerosis and related disorders
Related parts vol. 10
-- p. 86-89
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.msard.2016.09.012">https://doi.org/10.1016/j.msard.2016.09.012</a>
Public note Available from publisher's website

No items available.